FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.

被引：0
|
作者：
Sridhar, Srikala S.
Power, Nicholas
Breau, Rodney H.
Cheng, Susanna Y.
Pond, Gregory Russell
Chung, Peter W. M.
Metser, Ur
Levine, Mark Norman
Mukherjee, Som D.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[5] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada
[6] Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Princess Margaret Hosp, Toronto, ON, Canada
[8] Ontario Clin Oncol Grp, Hamilton, ON, Canada
[9] McMaster Univ, Dept Oncol, Juravinski Canc Ctr, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
460
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in patients (pts) with impaired renal function.
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zahoor, Haris
    Rybicki, Lisa A.
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr Farouk
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Martin, Allison
    Allman, Kimberly D.
    Beach, Jennifer
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery
    Chanza, Nieves Martinez
    Hamid, Anis
    Salgado, Roberto
    Gevaert, Thomas
    Maetens, Marion
    Rorive, Sandrine
    Aftimos, Philippe Georges
    Sideris, Spyridon
    Gil, Thierry
    Awada, Ahmad
    Roumeguere, Thierry Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Muscle invasive bladder cancer (MIBC) demonstrates neoadjuvant cisplatin-based chemotherapy (NAC) related changes in molecular subtype and immune infiltration.
    Funt, Samuel Aaron
    Solovyov, Alexander
    Faltas, Bishoy Morris
    Iyer, Gopa
    Boyd, Mariel Elena
    Cipolla, Catharine Kline
    Regazzi, Ashley Marie
    Teo, Min Yuen
    Lee, Chung-Han
    Al-Ahmadie, Hikmat
    Rosenberg, Jonathan E.
    Greenbaum, Benjamin
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [4] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    PLOS ONE, 2016, 11 (05):
  • [5] Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study
    Elkarta, Ahmed
    Awadalla, Amira
    El-hefnawy, Ahmed
    Mosbah, Ahmed
    Abolenein, Hassan
    Shokeir, Ahmed
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 38 - 46.e1
  • [6] Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC).
    Miron, Benjamin
    Ross, Eric A.
    Anari, Fern
    O'Neill, John
    Hoffman-Censits, Jean H.
    Zibelman, Matthew R.
    Kutikov, Alexander
    Viterbo, Rosalia
    Greenberg, Richard E.
    Chen, David
    Lallas, Costas D.
    Trabulsi, Edouard John
    Alpaugh, R. Katherine
    Dulaimi, Essel
    Golemis, Erica
    Uzzo, Robert
    Plimack, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).
    Tsironis, George
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Tzanis, Kimon
    Varkarakis, John
    Papatsoris, Athanasios
    Stravodimos, Kostas
    Kostouros, Efthymios
    Fragkoulis, Charalampos
    Choreftaki, Theodosia
    Filippiadis, Dimitrios
    Fontara, Sofia
    Dellis, Athanasios
    Ntai, Sparti
    Zygogianni, Anna
    Ntoumas, Konstantinos
    Constantinides, Constantinos A.
    Korkolopoulou, Penelope
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
    Soubra, Ayman
    Gencturk, Mehmet
    Froelich, Jerry
    Balaji, Priya
    Gupta, Shilpa
    Jha, Gautam
    Konety, Badrinath R.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 360 - 364
  • [9] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Kim, Philip H.
    Kent, Matthew
    Zhao, Philip
    Sfakianos, John P.
    Bajorin, Dean F.
    Bochner, Bernard H.
    Dalbagni, Guido
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 453 - 459
  • [10] Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Pond, Gregory Russell
    Curran, Catherine
    Freeman, Dory
    Ravi, Praful
    Mossanen, Matthew
    Preston, Mark A.
    Steele, Graeme S.
    Mantia, Charlene
    McGregor, Bradley Alexander
    Jain, Rakesh K.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345